Brokerages Give Buy, Hold, or Moderate Buy Ratings to Several Stocks

Several NASDAQ-listed companies received consensus ratings from brokerages. Notably, Rhythm Pharmaceuticals and Five Below were given a 'Moderate Buy' rating, while multiple companies were rated 'Hold' by analysts.

Rhythm Pharmaceuticals Inc. and Five Below Inc. received a consensus rating of 'Moderate Buy' from brokerages, signifying a positive outlook for these companies. Several other NASDAQ-listed companies received a rating of 'Hold' from analysts, including Heritage Commerce Corp, Amphastar Pharmaceuticals, and Gladstone Investment Corporation.

These ratings indicate that, while some brokerages are optimistic about these companies' prospects, others remain neutral, suggesting continued caution for investors. Analysts' assessments are influenced by factors including financial performance, market trends, and competition within their respective industries.

The ratings are based on aggregate analyst recommendations, emphasizing the collective perspective of various brokerage firms.